Come up with a name for your new list and we'll add to it:
Alzheon raised a round of funding on April 08, 2015. Investors include
Ally Bridge Group.
Alzheon is a clinical-stage biotechnology company focused on developing first-in-class therapeutic platforms for both disease modification and symptomatic relief of Alzheimer's disease. The company is…